Evidence map›Paper›PMID 26371971›Full record

ArticleBiomaterials science2015

Protein-engineered scaffolds for in vitro 3D culture of primary adult intestinal organoids.

Rebecca L DiMarco, Ruby E Dewi, Gabriela Bernal, Calvin Kuo, Sarah C Heilshorn

Abstract read
In one paragraph

Article in Biomaterials science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Article
  2. AnBiofabrication · 2025
    Article
  3. Article
  4. Engineering CAR-T Therapeutics for Enhanced Solid Tumor Targeting.Advanced materials (Deerfield Beach, Fla.) · 2025
    Review
  5. Review
  6. Review
  7. Review
  8. Organoid scaffold materials: research and application.Frontiers in bioengineering and biotechnology · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Listen to Your Gut: Key Concepts for Bioengineering Advanced Models of the Intestine.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Human organoids in basic research and clinical applications.Signal transduction and targeted therapy · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rebecca L DiMarcoStanford University Department of Bioengineering, USA.
Ruby E Dewi
Gabriela Bernal
Calvin Kuo
Sarah C Heilshorn

Funding

Stanford/UNC Biomimetic U19 Research CenterU19AI116484 · NIAID · STANFORD UNIVERSITY · PI AMIEVA, MANUEL R · 2015 to 2025
$13.5M
Regulation of actively proliferating and quiescent intestinal stem cellsU01DK085527 · NIDDK · STANFORD UNIVERSITY · PI KUO, CALVIN J · 2009 to 2023
$6.9M
Intestinal Stem Cell Consortium Coordinating CenterU01DK085532 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NILAND, JOYCE CAROL · 2009 to 2018
$6.5M
Three-dimensional Scaffold-based Systems for Primary Human Intestinal CultureR01DK085720 · NIDDK · STANFORD UNIVERSITY · PI KUO, CALVIN J · 2009 to 2013
$3.7M
Engineering 3D in vitro niches to reveal fundamentals of cellular biomechanicsDP2OD006477 · OD · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C · 2009 to 2009
$2.4M
Limited Competition for the Continuation of the Intestinal Stem Cell Consortium Coordinating CenterU24DK085532 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NILAND, JOYCE CAROL · 2019 to 2023
$2.3M
Engineered Intestinal Microenvironments as Preclinical Drug Screening PlatformsR21EB018407 · NIBIB · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C · 2014 to 2015
$427k
NIAID NIH HHS 1U19AI116484-01NIAID NIH HHS U19 AI116484NIBIB NIH HHS 1R21-EB018407-01NIBIB NIH HHS R21 EB018407NIDDK NIH HHS R01 DK085720NIDDK NIH HHS R01 DK085720-01NIDDK NIH HHS U01 DK085527NIDDK NIH HHS U01DK085527NIDDK NIH HHS U01 DK085532NIDDK NIH HHS U24 DK085532NIH HHS 1DP2-OD006477-01NIH HHS DP2 OD006477
6 · The paper itself

Abstract

Though in vitro culture of primary intestinal organoids has gained significant momentum in recent years, little has been done to investigate the impact of microenvironmental cues provided by the encapsulating matrix on the growth and development of these fragile cultures. In this work, the impact of various in vitro culture parameters on primary adult murine organoid formation and growth are analyzed with a focus on matrix properties and geometric culture configuration. The air-liquid interface culture configuration was found to result in enhanced organoid formation relative to a traditional submerged configuration. Additionally, through use of a recombinantly engineered extracellular matrix (eECM), the effects of biochemical and biomechanical cues were independently studied. Decreasing mechanical stiffness and increasing cell adhesivity were found to increase organoid yield. Tuning of eECM properties was used to obtain organoid formation efficiency values identical to those observed in naturally harvested collagen I matrices but within a stiffer construct with improved ease of physical manipulation. Increased ability to remodel the surrounding matrix through mechanical or enzymatic means was also shown to enhance organoid formation. As the engineering and tunability of recombinant matrices is essentially limitless, continued property optimization may result in further improved matrix performance and may help to identify additional microenvironmental cues that directly impact organoid formation, development, differentiation, and functional behavior. Continued culture of primary organoids in recombinant matrices could therefore prove to be largely advantageous in the field of intestinal tissue engineering for applications in regenerative medicine and in vitro tissue mimics.

Indexed as

AnimalsCell AdhesionCell DifferentiationCollagen Type IExtracellular MatrixIntestinesMiceMice, Inbred C57BLOrgan Culture TechniquesOrganoidsTissue EngineeringCollagen Type I

Identifiers

PMID26371971
PMCPMC9063856

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.